Literature DB >> 1736250

The organization and delivery of clinical genetics services.

B A Bernhardt1, R E Pyeritz.   

Abstract

Advances in genetics, including mapping the human genome, improved therapy for genetic disorders, recognition of the role of genetic factors in common diseases of adulthood, and new screening tests for carrier detection and presymptomatic diagnosis create an increased demand for and awareness of clinical genetic services. These services, focusing on diagnosis, management, and genetic counseling, had been supported by a variety of state, provincial, federal, and foundation grants. As clinical genetics has evolved from a service with roots in research provided solely at academic medical centers to one widely available in the community, the services in the United States are increasingly provided on a fee-for-service basis in various settings including private hospitals, state-supported outreach clinics, and free-standing genetics centers, whereas in Canada they are generally based in university hospital settings and are covered by universal health care. Given the limited numbers of clinical geneticists and genetic counselors now practicing, much of the application in this decade of new genetic technologies and knowledge will fall upon primary care physicians.

Entities:  

Mesh:

Year:  1992        PMID: 1736250     DOI: 10.1016/s0031-3955(16)38259-1

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  6 in total

1.  Billing for medical genetics and genetic counseling services: a national survey.

Authors:  Tabitha A Harrison; Debra Lochner Doyle; Caroline McGowan; Leslie Cohen; Elizabeth Repass; Ruthann B Pfau; Trish Brown
Journal:  J Genet Couns       Date:  2009-10-07       Impact factor: 2.537

2.  Using Public-Private Partnerships to Mitigate Disparities in Access to Genetic Services: Lessons from Wisconsin.

Authors:  Laura Senier; Matthew Kearney; Jason Orne
Journal:  Adv Med Sociol       Date:  2015

Review 3.  Alglucerase. A pharmacoeconomic appraisal of its use in the treatment of Gaucher's disease.

Authors:  R Whittington; K L Goa
Journal:  Pharmacoeconomics       Date:  1995-01       Impact factor: 4.981

4.  Ethical and professional challenges posed by patients with genetic concerns: a report of focus group discussions with genetic counselors, physicians, and nurses.

Authors:  P M Veach; D M Bartels; B S LeRoy
Journal:  J Genet Couns       Date:  2001-04       Impact factor: 2.537

5.  What do clinicians derive from partnering with their patients? A reliable and valid measure of "personal meaning in patient care".

Authors:  Gail Geller; Barbara A Bernhardt; Joseph Carrese; Cynda H Rushton; Ken Kolodner
Journal:  Patient Educ Couns       Date:  2008-05-15

6.  Blending Insights from Implementation Science and the Social Sciences to Mitigate Inequities in Screening for Hereditary Cancer Syndromes.

Authors:  Laura Senier; Colleen M McBride; Alex T Ramsey; Vence L Bonham; David A Chambers
Journal:  Int J Environ Res Public Health       Date:  2019-10-15       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.